Atossa Genetics Inc Stock
Atossa Genetics Inc Stock
A very strong showing by Atossa Genetics Inc today, with an increase of €0.037 (5.670%) compared to yesterday's price.
Atossa Genetics Inc is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
Based on the current price of 0.68 € the target price of 6 € shows a potential of 779.77% for Atossa Genetics Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Atossa Genetics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Atossa Genetics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atossa Genetics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atossa Genetics Inc | 5.670% | 0.442% | -5.671% | -39.646% | -29.400% | -2.738% | -44.755% |
| Aortech International plc | - | 0.515% | -7.143% | 1.036% | -12.946% | -72.765% | -94.948% |
| Theralase Technologies Inc | -4.710% | -0.613% | -26.364% | -52.907% | -49.375% | -61.058% | -28.319% |
| Medmira Inc. | -6.760% | -15.854% | -12.658% | -31.000% | -56.875% | -16.867% | - |
Comments
Atossa Genetics (NASDAQ:ATOS) had its price target raised by analysts at Ascendiant Capital Markets from $7.50 to $7.75. They now have a "buy" rating on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its price target raised by analysts at Ascendiant Capital Markets from $7.25 to $7.50. They now have a "buy" rating on the stock.
Show more
Ratings data for ATOS provided by MarketBeat
Atossa Therapeutics, Inc. (NASDAQ: ATOS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $4.00 price target on the stock.
Show more
Ratings data for ATOS provided by MarketBeat